Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial
Titel:
Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial
Auteur:
Platzbecker, Uwe Wong, Raymond S M Verma, Amit Abboud, Camille Araujo, Sergio Chiou, Tzeon-Jye Feigert, John Yeh, Su-Peng Götze, Katharina Gorin, Norbert-Claude Greenberg, Peter Kambhampati, Suman Kim, Yoo-Jin Lee, Je-Hwan Lyons, Roger Ruggeri, Marco Santini, Valeria Cheng, Gregory Jang, Jun Ho Chen, Chien-Yuan Johnson, Brendan Bennett, John Mannino, Frank Kamel, Yasser Mostafa Stone, Nicole Dougherty, Souria Chan, Geoffrey Giagounidis, Aristoteles